Aberrant STAT3 signaling exerts oncogenic effects by promoting tumor proliferation, survival, chemoresistance, invasion, metastasis, angiogenesis, immunosuppression, and tumor-related inflammation (6). This evidence concerns the gene STAT3 and neoplasm.